How Untreated Sleep Apnea May Raise Your Risk of Blood Clots in the Legs and Lungs
What the latest European research says about sleep apnea and blood clots
Around seven in ten people admitted with a clot turn out to have sleep apnea on an overnight study, and fewer than one in ten has it written anywhere in their notes.
The short answer on sleep apnea and blood clots
Sleep apnea and blood clots are linked. Untreated apnea is associated with a higher rate of venous clots, more strongly in the lungs than the legs. One nationwide cohort matched 133,245 adults with newly diagnosed obstructive sleep apnea against 629,994 controls, followed for 7.5 years. Venous thromboembolism ran at 287.5 versus 205.0 events per 100,000 person-years, a 68% higher risk (Kim et al., SLEEP, 2026). That is an association, not proof. It is still worth raising with your doctor, along with how far your oxygen falls while you sleep.
One more figure changes what you do next. Among patients admitted with an acute clot and given an overnight sleep study, 70% had an apnea-hypopnea index (AHI) of 5 or more and 41% reached moderate-to-severe levels. Only 8% had sleep apnea in their notes (Carrera-Cueva et al., Archivos de Bronconeumología, 2026). Roughly nine in ten whose clot may be tied to their breathing have never been tested.
- Diagnosed sleep apnea carried a 68% higher rate of venous thromboembolism in a 2026 cohort.
- Most people admitted with a clot who have apnea are never diagnosed.
- This is association, not established cause. Treat it as a reason to test.
How sleep apnea and blood clots may be connected in the body
Clot formation needs three conditions, known as Virchow's triad: blood that clots too readily, blood that moves too slowly, a damaged vessel lining. A systematic review mapped the apnea evidence onto all three (Raj et al., Cureus, 2022).
Repeated oxygen drops change the blood itself
Every apnea event drops your oxygen, then floods it back. That cycle is intermittent hypoxia and reoxygenation, and it is associated with a procoagulant state: blood that clots more easily than it should. Markers named in that review include the thrombin-antithrombin (TAT) complex, fibrinogen, factor VIIa, von Willebrand factor, D-dimer and plasminogen activator inhibitor-1 (PAI-1).
Blood moves more slowly and thickly
Venous stasis means blood pooling instead of returning. Raised haematocrit and plasma viscosity, both described in the same review, slow that return further. Slow blood is clot-friendly blood.
The vessel lining stops working properly
Endothelial dysfunction means the lining of your blood vessels loses its normal anti-clotting behaviour. Reduced nitric oxide bioavailability and increased platelet activation are the usual explanations. The European Respiratory Society links intermittent hypoxia and sleep fragmentation to increased blood coagulability, endothelial dysfunction and venous stasis (Garcia-Ortega et al., European Respiratory Journal, 2019).
- The proposed mechanism touches all three legs of Virchow's triad at once.
- Lung-clot patients are two to four times more likely to have moderate-to-severe apnea, so the link runs both ways.
Why a leg clot and a lung clot are not the same question
Deep vein thrombosis (DVT) is a clot in a deep vein, usually the calf or thigh. Pulmonary embolism (PE) is what happens when part of it travels to the lungs. Most pages on sleep apnea and blood clots treat the two as one topic. The data does not.
| Finding | Deep vein thrombosis | Pulmonary embolism |
|---|---|---|
| Adjusted hazard ratio, 133,245 adults with apnea (Kim et al., SLEEP, 2026) | 1.54 (95% CI 1.44-1.65) | 1.82 (95% CI 1.71-1.93) |
| 38,621 patients (Peng 2014, in Raj et al., Cureus, 2022) | 3.50-fold higher risk | 3.97-fold higher risk |
| 258,455 patients (D'Apuzzo 2012, in Raj et al., Cureus, 2022) | Not reported separately | Odds ratio 2.02 (95% CI 1.3-2.9) |
| Repeat clot risk (Xu 2020 meta-analysis, in Raj et al., Cureus, 2022) | Not reported separately | Relative risk 3.87 (95% CI 1.65-9.07) |
If you are recovering from a pulmonary embolism, you sit in the column with the stronger association and the recurrence signal. After a calf DVT it is real but smaller. Severity matters too. The excess DVT risk in one cohort sat at an AHI above 30 (Bahar 2019, in Raj et al., Cureus, 2022), and the acute-clot meta-analysis put the meaningful group at an AHI of 15 and above (Carrera-Cueva et al., Archivos de Bronconeumología, 2026).
Bring the right paperwork. A leg clot is confirmed by compression ultrasound, also called duplex venous ultrasound; a lung clot by CT pulmonary angiography (CTPA). If your follow-up names post-thrombotic syndrome after a DVT, or chronic thromboembolic pulmonary hypertension (CTEPH) after a PE, bring that too. Obesity and higher BMI raise the risk of both conditions, so some of the overlap is shared risk.
- Pulmonary embolism showed a hazard ratio of 1.82 against 1.54 for DVT (SLEEP, 2026).
- Tell your clinician which clot you had. It changes how urgent the sleep question is.
What your national health service leaves off the list
Check the official patient page and you find nothing about this. The NHS page on sleep apnoea lists high blood pressure, stroke risk, type 2 diabetes, heart disease, depression and accidents from fatigue among the problems apnoea can cause. Blood clots, DVT and pulmonary embolism are not there. France's Assurance Maladie page lists arrhythmia, hypertension, coronary disease with infarction risk, stroke and heart failure. Thrombose veineuse, phlebite and embolie pulmonaire are absent too.
This is not negligence. Guidance moves slower than journals, and the strongest cohort data landed between 2024 and 2026. It does mean a European reader who checked the official source has been told nothing about sleep apnea and blood clots, only about the arterial complications that both lists do include.
Language matters when you go looking. The pairing is apnée du sommeil et thrombose veineuse or embolie pulmonaire in French, Schlafapnoe und Thrombose or Lungenembolie in German, apnea del sueño y trombosis venosa or embolia pulmonar in Spanish. Search the pairing, not either word alone.
Those European figures come from the VITAE study (Cohen et al., Thrombosis and Haemostasis, 2007), which also found 34% of clot deaths were sudden fatal pulmonary embolism and 59% followed a PE that had never been diagnosed. Detection, not treatment, is where most of the loss happens.
- Neither the NHS nor ameli.fr lists blood clots among the complications of untreated apnea.
- Only 7% of those clot deaths were diagnosed beforehand, so never wait out new symptoms.
Where the standard advice on sleep apnea and blood clots breaks down
Two pieces of routine practice fail in this group. Knowing both lets you steer your own care.
Flaw one, the screening questionnaire misses too many people
Most doctors screen with the STOP-Bang questionnaire, sometimes alongside the Epworth Sleepiness Scale. It underperforms here. In 268 patients hospitalised with acute symptomatic pulmonary embolism who then had an overnight sleep study, 47% had obstructive sleep apnea. STOP-Bang scored an AUC of 0.65, a 22.4% false-negative rate, and sensitivity of 89.8% overall but only 80.4% in women against 97.2% in men (Briceno et al., SLEEP, 2024). A woman told her score is low risk should still ask for the study.
Flaw two, treating the apnea is not yet proven to stop the next clot
This cuts against what most pages imply. A French prospective cohort followed 2,109 patients with venous thromboembolism for a median 4.8 years, including 74 with moderate-to-severe apnea. After anticoagulation stopped, the risk of a repeat clot and of death from any cause was not increased in the apnea group (Nepveu, Couturaud et al., Thrombosis Journal, 2022). A 2025 Canadian Respiratory Journal review called the evidence insufficient to say CPAP prevents recurrent clots.
The blood work points the same way. In 57 patients with severe apnea given six months of CPAP, fibrinogen fell significantly (3.665 to 3.365, p=0.0075), while D-dimer rose (415 to 499, p=0.0282) and PAI-1 did not move (Biomedicines, 2024). In the Swedish RICCADSA randomised trial of revascularised coronary patients with moderate-to-severe apnea, CPAP significantly reduced VCAM-1, yet the fibrinolytic imbalance appeared largely resistant to treatment. Read together, the sources say something none of them says alone: apnea treatment improves parts of the vascular profile without demonstrably resetting the clotting side.
- STOP-Bang missed 22.4% of cases in acute PE patients and performed worst in women (SLEEP, 2024).
- A French cohort found no rise in recurrence after stopping anticoagulation in moderate-to-severe apnea (Thrombosis Journal, 2022).
- CPAP lowered fibrinogen in one 2024 study while D-dimer rose, so do not assume treatment cancels the risk.
What the sleep investigation actually involves in Europe
The test has different names depending on where you live. France's first-line study is a polygraphie ventilatoire nocturne, at least six hours of ECG and respiratory movement. Polysomnographie is the fuller version, adding brain, muscle and eye-movement channels. Elsewhere the same idea is called a home sleep apnoea test, or HSAT. In the UK, a GP refers you to an NHS sleep clinic.
| Where you are | What to ask for | What you get back |
|---|---|---|
| France | Polygraphie ventilatoire nocturne, then polysomnographie if inconclusive | At least six hours of ECG and respiratory movement, giving your IAH |
| United Kingdom | A GP referral to an NHS specialist sleep clinic | The clinic sets the test; ask for the AHI figure |
| Still an inpatient after a clot | A sleep study before you are discharged | Testing within seven days of diagnosis in the Spanish PE study, on the ward |
Your result comes back as an index. In France it is the IAH, the indice d'apnées-hypopnées, banded by ameli.fr as mild from 5 to 15, moderate from 16 to 30, severe above 30. Those bands drive access. PPC (pression positive continue, the French term for CPAP) is covered at an IAH of 30, or from 15 to 30 with documented micro-arousals or associated cardiorespiratory conditions. The orthèse d'avancée mandibulaire (OAM), a mandibular advancement device, is covered from 15 to 30. Renewal is conditional: the appliance needs a 50% fall in the apnea-hypopnea index after two years, PPC needs satisfactory adherence over 28 days.
- Ask for a polygraphie ventilatoire nocturne in France, a GP sleep-clinic referral in the UK.
- Still on the ward after a clot, ask for the study before you go home.
A four-step plan you can start this week
The European Respiratory Journal review closes by calling for closer collaboration between sleep medicine and venous thromboembolism teams. Translated: the two teams often do not talk, so you carry the information.
1Write down the three facts both teams will want
Which clot you had and when, whether it was provoked or unprovoked, and which anticoagulation you take: a direct oral anticoagulant (DOAC) such as rivaroxaban or apixaban, or a vitamin K antagonist. Add whether anyone has seen you stop breathing or gasp in your sleep. A partner's report carries weight.
2Ask for the sleep study, not just the questionnaire
Request the overnight recording explicitly. If your screening score is called reassuring, mention that STOP-Bang produced a 22.4% false-negative rate in hospitalised pulmonary embolism patients, and did worse in women (Briceno et al., SLEEP, 2024).
3Decide who owns the question before you leave the room
Name one owner: your GP, the sleep or respiratory clinic, or the thrombosis clinic. Ask for it in the letter. The commonest failure is each side assuming the other is handling it.
4Get your index number and your severity band
Ask for the actual AHI or IAH figure plus your oxygen desaturation index (ODI), not a verbal summary. Those numbers determine treatment access later.
Five minutes with a clinician, in this order:
- Do I meet the threshold for an overnight sleep study, and can it happen before discharge?
- What was my apnea-hypopnea index, and what was my oxygen desaturation index?
- Which team is recording this as theirs, sleep medicine or thrombosis?
- Does anything about my night-time breathing change how long I stay on anticoagulation?
- Assign one owning team in writing, or the question falls between specialties.
- Raise surgery, flights and bed rest before they happen, not after.
Surgery, flights and other high-risk windows
Sleep apnea and blood clots meet most sharply in the windows where you stop moving. Studies of consecutive joint-replacement patients report higher odds of pulmonary embolism, and of venous clots overall, in those with apnea. Surgery is planned, which makes it a plannable conversation. Tell the surgical team about your apnea, or your suspicion of it, at the pre-operative assessment rather than on the day.
Long-haul travel deserves the same handling. If you use a machine, settle the practical side of taking CPAP on a flight within Europe before you book. Movement, hydration and any compression measures your clinician advises still apply. Pregnancy is another window to flag early with your maternity team.
- Surgical cohorts link apnea to higher pulmonary embolism odds, so declare it early.
- Suspected but undiagnosed apnea still counts at a pre-operative assessment.
Where devices fit, and where they do not
Anyone recovering from a DVT or pulmonary embolism needs a sleep investigation first, not a product. That is why this article stayed device-neutral until here.
After the study, your index number sets the route; the French bands above show how. Positional therapy and inclined-bed sleep circulate widely online, but no study cited here tested sleeping position against clot risk. Treat those as comfort measures, not clot prevention.
Back2Sleep is a CE-certified Class I soft silicone intranasal stent that keeps the nasal airway open during sleep, with no prescription, no electricity and no tubing. It is intended for snoring and mild-to-moderate obstructive sleep apnea. That is the band where the clot evidence above is thinnest, since almost every signal here comes from moderate-to-severe disease. It is not a CPAP replacement, not a treatment for severe apnea, and not an answer for anyone recovering from a clot. For calibration, a systematic review of 17 studies and 496 participants found external nasal dilators produced no significant difference in apnea-hypopnea index or snoring index against controls, and positioned them as adjunctive for mild symptoms or nasal congestion (Cureus, 2026). A nasopharyngeal stent differs from an external nasal-valve dilator, so that review is adjacent evidence, not a verdict.
- Sleep study first, since no device substitutes for knowing your index number.
- Machine therapy, oral appliances and nasal devices suit different severity bands.
- The clot evidence concerns moderate-to-severe apnea, which no over-the-counter nasal device is indicated to treat.
What Back2Sleep Users Say
Frequently Asked Questions
Can sleep apnea cause blood clots in the lungs?
The research shows an association, not proven cause. In a cohort of 133,245 adults with obstructive sleep apnea, pulmonary embolism risk was 82% higher than in matched controls (Kim et al., SLEEP, 2026). Apnea is linked to a procoagulant state, slower venous flow and vessel-lining damage, which together may raise clot risk.
Should I be tested for sleep apnea after a DVT or pulmonary embolism?
It is worth requesting. Among patients admitted with an acute clot, 70% had an apnea-hypopnea index of 5 or more, yet only 8% had a recorded diagnosis (Carrera-Cueva et al., Archivos de Bronconeumología, 2026). In one Spanish study the sleep study happened within seven days of diagnosis, while patients were still inpatients.
Does CPAP reduce the risk of getting another blood clot?
Not proven. A French cohort of 2,109 clot patients found that recurrence and death after stopping anticoagulation were not increased in moderate-to-severe apnea (Nepveu et al., Thrombosis Journal, 2022), and a 2025 Canadian Respiratory Journal review called the evidence insufficient. Treat CPAP as apnea treatment, not as clot prevention.
Is CPAP contraindicated after a pulmonary embolism?
Nothing in the research cited here identifies CPAP as unsafe after a pulmonary embolism. The open question is whether it prevents another clot. In one Spanish study, patients hospitalised with acute PE were given overnight sleep studies during admission. Confirm your own case with the team managing your anticoagulation.
What is the difference between polygraphie ventilatoire nocturne and polysomnography?
In France the polygraphie ventilatoire nocturne is the first-line sleep test, recording at least six hours of ECG and respiratory movement to produce your IAH. Polysomnographie adds brain, muscle and eye-movement channels. Elsewhere the first-line version is usually called a home sleep apnoea test, or HSAT.
Can you die in your sleep from a pulmonary embolism?
Pulmonary embolism can be fatal. Across six EU countries, 34% of clot-related deaths were sudden fatal PE and 59% followed a PE never diagnosed in life (Cohen et al., Thrombosis and Haemostasis, 2007). Sudden breathlessness, chest pain or coughing blood needs emergency care immediately, not a wait-and-see approach.
Do I need to tell my surgeon about sleep apnea before an operation?
Yes, raise it at the pre-operative assessment. Studies of joint-replacement patients report higher odds of pulmonary embolism, and of venous clots overall, in people with obstructive sleep apnea. Suspected but undiagnosed apnea counts too, so mention snoring or witnessed breathing pauses even without a formal diagnosis.
What is the best sleeping position after a pulmonary embolism?
No study cited here tested sleeping position against clot risk, so treat position advice online as comfort rather than prevention. The evidence-backed action after a pulmonary embolism is a sleep investigation and the anticoagulation plan your team sets. Report new breathlessness or chest pain as an emergency, not a positioning problem.
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.